Remedium Lifecare Ltd vs Sotac Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Remedium Lifecare Ltd is ₹ 0.39 as of 13 Apr 15:30 . The P/E Ratio of Remedium Lifecare Ltd changed from 36.4 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Sotac Pharmaceuticals Ltd changed from 16.4 on March 2025 to 31.3 on March 2024 . This represents a CAGR of 17.54% over 4 years The Market Cap of Remedium Lifecare Ltd changed from ₹ 73.38 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Sotac Pharmaceuticals Ltd changed from ₹ 131.22 crore on March 2025 to ₹ 133.71 crore on March 2024 . This represents a CAGR of 0.47% over 4 years The revenue of Remedium Lifecare Ltd for the Sep '25 is ₹ 114.31 crore as compare to the Jun '25 revenue of ₹ 116.84 crore. This represent the decline of -2.17% The revenue of Sotac Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Remedium Lifecare Ltd for the Sep '25 is ₹ 10.62 crore as compare to the Jun '25 ebitda of ₹ 5.35 crore. This represent the growth of 98.5% The ebitda of Sotac Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Remedium Lifecare Ltd changed from ₹ -2.05 crore to ₹ 8.62 crore over 3 quarters. This represents a CAGR of NaN% The net profit of Sotac Pharmaceuticals Ltd changed from ₹ 1.35 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sotac Pharmaceuticals Ltd changed from 13.94 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
Thereafter 'M/s.
Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.

FAQs for the comparison of Remedium Lifecare Ltd and Sotac Pharmaceuticals Ltd

Which company has a larger market capitalization, Remedium Lifecare Ltd or Sotac Pharmaceuticals Ltd?

Market cap of Remedium Lifecare Ltd is 38 Cr while Market cap of Sotac Pharmaceuticals Ltd is 117 Cr

What are the key factors driving the stock performance of Remedium Lifecare Ltd and Sotac Pharmaceuticals Ltd?

The stock performance of Remedium Lifecare Ltd and Sotac Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remedium Lifecare Ltd and Sotac Pharmaceuticals Ltd?

As of May 5, 2026, the Remedium Lifecare Ltd stock price is INR ₹0.44. On the other hand, Sotac Pharmaceuticals Ltd stock price is INR ₹106.0.

How do dividend payouts of Remedium Lifecare Ltd and Sotac Pharmaceuticals Ltd compare?

To compare the dividend payouts of Remedium Lifecare Ltd and Sotac Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.